FDA approves a new version of Primatene Mist, the only OTC metered-dose inhaler. Primatene Mist is approved by the FDA as an OTC drug to provide temporary relief for symptoms of mild, intermittent asthma. Primatene Mist is only approved for those who have been diagnosed with asthma by a health care provider. The FDA advises that Primatene Mist is not a replacement for prescription asthma treatments.
A different version of OTC Primatene Mist was taken off the market in 2011 because it contained ozone-depleting element chlorofluorocarbon (CFC) propellants. This current version replaced CFC propellants with hydrofluoroalkane (HFAs) propellants, which are permitted under current international and U.S. law.
Read the safety precautions associated with Primatene Mist here.